Cargando…
S246: JAK/ROCK INHIBITOR TQ05105 FOR GLUCOCORTICOID-REFRACTORY OR -DEPENDENT CHRONIC GRAFT-VERSUS-HOST DISEASE: UPDATED RESULTS OF A PHASE 1B/2 STUDY
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428415/ http://dx.doi.org/10.1097/01.HS9.0000967896.90637.56 |
| _version_ | 1785090463599951872 |
|---|---|
| author | Zhao, Yanmin Tu, Lifan Luo, Yi Shi, Jimin Ye, Yishan Yu, Jian Yu, Yi Wang, Shunqing Meng, Fankai Jiang, Erlie Zhu, Xiaoyu Yu, Yang Huang, He |
| author_facet | Zhao, Yanmin Tu, Lifan Luo, Yi Shi, Jimin Ye, Yishan Yu, Jian Yu, Yi Wang, Shunqing Meng, Fankai Jiang, Erlie Zhu, Xiaoyu Yu, Yang Huang, He |
| author_sort | Zhao, Yanmin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428415 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104284152023-08-17 S246: JAK/ROCK INHIBITOR TQ05105 FOR GLUCOCORTICOID-REFRACTORY OR -DEPENDENT CHRONIC GRAFT-VERSUS-HOST DISEASE: UPDATED RESULTS OF A PHASE 1B/2 STUDY Zhao, Yanmin Tu, Lifan Luo, Yi Shi, Jimin Ye, Yishan Yu, Jian Yu, Yi Wang, Shunqing Meng, Fankai Jiang, Erlie Zhu, Xiaoyu Yu, Yang Huang, He Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428415/ http://dx.doi.org/10.1097/01.HS9.0000967896.90637.56 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Zhao, Yanmin Tu, Lifan Luo, Yi Shi, Jimin Ye, Yishan Yu, Jian Yu, Yi Wang, Shunqing Meng, Fankai Jiang, Erlie Zhu, Xiaoyu Yu, Yang Huang, He S246: JAK/ROCK INHIBITOR TQ05105 FOR GLUCOCORTICOID-REFRACTORY OR -DEPENDENT CHRONIC GRAFT-VERSUS-HOST DISEASE: UPDATED RESULTS OF A PHASE 1B/2 STUDY |
| title | S246: JAK/ROCK INHIBITOR TQ05105 FOR GLUCOCORTICOID-REFRACTORY OR -DEPENDENT CHRONIC GRAFT-VERSUS-HOST DISEASE: UPDATED RESULTS OF A PHASE 1B/2 STUDY |
| title_full | S246: JAK/ROCK INHIBITOR TQ05105 FOR GLUCOCORTICOID-REFRACTORY OR -DEPENDENT CHRONIC GRAFT-VERSUS-HOST DISEASE: UPDATED RESULTS OF A PHASE 1B/2 STUDY |
| title_fullStr | S246: JAK/ROCK INHIBITOR TQ05105 FOR GLUCOCORTICOID-REFRACTORY OR -DEPENDENT CHRONIC GRAFT-VERSUS-HOST DISEASE: UPDATED RESULTS OF A PHASE 1B/2 STUDY |
| title_full_unstemmed | S246: JAK/ROCK INHIBITOR TQ05105 FOR GLUCOCORTICOID-REFRACTORY OR -DEPENDENT CHRONIC GRAFT-VERSUS-HOST DISEASE: UPDATED RESULTS OF A PHASE 1B/2 STUDY |
| title_short | S246: JAK/ROCK INHIBITOR TQ05105 FOR GLUCOCORTICOID-REFRACTORY OR -DEPENDENT CHRONIC GRAFT-VERSUS-HOST DISEASE: UPDATED RESULTS OF A PHASE 1B/2 STUDY |
| title_sort | s246: jak/rock inhibitor tq05105 for glucocorticoid-refractory or -dependent chronic graft-versus-host disease: updated results of a phase 1b/2 study |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428415/ http://dx.doi.org/10.1097/01.HS9.0000967896.90637.56 |
| work_keys_str_mv | AT zhaoyanmin s246jakrockinhibitortq05105forglucocorticoidrefractoryordependentchronicgraftversushostdiseaseupdatedresultsofaphase1b2study AT tulifan s246jakrockinhibitortq05105forglucocorticoidrefractoryordependentchronicgraftversushostdiseaseupdatedresultsofaphase1b2study AT luoyi s246jakrockinhibitortq05105forglucocorticoidrefractoryordependentchronicgraftversushostdiseaseupdatedresultsofaphase1b2study AT shijimin s246jakrockinhibitortq05105forglucocorticoidrefractoryordependentchronicgraftversushostdiseaseupdatedresultsofaphase1b2study AT yeyishan s246jakrockinhibitortq05105forglucocorticoidrefractoryordependentchronicgraftversushostdiseaseupdatedresultsofaphase1b2study AT yujian s246jakrockinhibitortq05105forglucocorticoidrefractoryordependentchronicgraftversushostdiseaseupdatedresultsofaphase1b2study AT yuyi s246jakrockinhibitortq05105forglucocorticoidrefractoryordependentchronicgraftversushostdiseaseupdatedresultsofaphase1b2study AT wangshunqing s246jakrockinhibitortq05105forglucocorticoidrefractoryordependentchronicgraftversushostdiseaseupdatedresultsofaphase1b2study AT mengfankai s246jakrockinhibitortq05105forglucocorticoidrefractoryordependentchronicgraftversushostdiseaseupdatedresultsofaphase1b2study AT jiangerlie s246jakrockinhibitortq05105forglucocorticoidrefractoryordependentchronicgraftversushostdiseaseupdatedresultsofaphase1b2study AT zhuxiaoyu s246jakrockinhibitortq05105forglucocorticoidrefractoryordependentchronicgraftversushostdiseaseupdatedresultsofaphase1b2study AT yuyang s246jakrockinhibitortq05105forglucocorticoidrefractoryordependentchronicgraftversushostdiseaseupdatedresultsofaphase1b2study AT huanghe s246jakrockinhibitortq05105forglucocorticoidrefractoryordependentchronicgraftversushostdiseaseupdatedresultsofaphase1b2study |